Stimulant Use Disorder
- Stimulant Use Disorder (cocaine and amphetamine-type stimulants)
- Core feature: A pattern of stimulant use leading to clinically significant impairment or distress, characterized by loss of control, continued use despite consequences, and physiological adaptation
- Lifetime prevalence: approximately 0.3% for cocaine use disorder and 0.2% for amphetamine-type stimulant use disorder in the US (rates vary significantly by region and population)
- Stimulant use disorder is unique among substance use disorders because there is no FDA-approved medication-assisted treatment. This makes it a critical teaching point: the absence of pharmacological options means psychosocial interventions - particularly contingency management and CBT - are not adjuncts to medication but the primary treatment. The other critical teaching point is the differential: stimulant intoxication mimics mania, stimulant-induced psychosis mimics primary psychotic disorders, and stimulant withdrawal mimics major depression. A urine drug screen is not optional - it is diagnostic.
Red Flags & Key Clinical Considerations
Diagnosing Bipolar Disorder Without a Urine Drug Screen
Stimulant intoxication and mania are clinically indistinguishable in a single cross-sectional evaluation. Both present with euphoria, grandiosity, pressured speech, decreased sleep, and impaired judgment. A UDS is the minimum required step before diagnosing a manic episode. Diagnosing bipolar disorder during active stimulant intoxication risks committing the patient to a lifelong mood disorder diagnosis and unnecessary mood stabilizer treatment based on a substance-induced episode.
Premature Diagnosis of Schizophrenia in the Context of Stimulant Use
Stimulant-induced psychosis, particularly from methamphetamine, can be indistinguishable from acute paranoid schizophrenia. The differentiator is time: stimulant-induced psychosis typically resolves within days to two weeks of abstinence. If psychotic symptoms persist beyond one month of documented abstinence, then a primary psychotic disorder should be considered. Diagnosing schizophrenia during active stimulant use or in the first weeks of abstinence is premature.
Diagnosing MDD During the Stimulant Crash
The stimulant withdrawal crash produces depressed mood, hypersomnia, fatigue, anhedonia, increased appetite, and psychomotor retardation - a clinical picture nearly identical to a major depressive episode. This resolves over days to weeks with sustained abstinence. Wait 2-4 weeks of documented abstinence before diagnosing independent MDD. Premature diagnosis leads to antidepressant treatment for a condition that may resolve spontaneously.
Assuming There Is No Treatment for Stimulant Use Disorder
The absence of FDA-approved medication does not mean stimulant use disorder is untreatable. Contingency management has strong evidence, CBT is effective, and community reinforcement approaches improve outcomes. Therapeutic nihilism about stimulant use disorder - the assumption that without a medication there is nothing to offer - is a clinical error that leads to undertreated patients and preventable morbidity.
Beta-Blockers in Cocaine Intoxication
Beta-blockers are classically avoided in cocaine-related cardiovascular emergencies due to the risk of unopposed alpha-adrenergic stimulation, which can worsen hypertension and coronary vasospasm. Benzodiazepines are first-line for cocaine-related agitation, hypertension, and chest pain. This is a frequently tested pharmacology point and a genuine patient safety issue.
References & Further Reading
This educational summary synthesizes information from standard clinical references for learning purposes. It is not a substitute for primary sources. Always verify against current clinical guidelines before applying any content in practice.
- American Psychiatric Association practice guidelines and current diagnostic standards (2022)
- SAMHSA TIP 63: Medications for Opioid Use Disorder (samhsa.gov)
Test your knowledge
Review flashcards on diagnostic criteria and key differentials, or build a custom quiz with board-style clinical vignettes.